Mutations in NF2 occur in schwannomas and meningiomas, as well as other types of cancer including GBM, hepatic, mesothelioma, breast, colorectal, skin, clear cell renal cell carcinoma, and prostate cancer (Petrilli & Fernández-Valle, 2016). This evidence concerns the gene NF2 and mesothelioma.